• Identification of Medicinal Products (IDMP) Standards Part 3: Steps to Prepare for IDMP Implementation

    26 April 2017

    Read More

Decision on EMA Relocation Set for November, Council Agrees on Bidding Procedure

23 June 2017

Read More

EMA Recommends New HCV, Cancer and MS Drugs for Approval

23 June 2017

Read More

Regulatory Recon: FDA Rejects Pfizer Epogen Biosimilar Over Warned Manufacturing Site; Novartis, CSL Behring & Roche Pick Up US Approvals (23 June 2017)

23 June 2017

Read More

Senate Health Bill Would Repeal Device Tax

22 June 2017

Read More

European Regulatory Roundup: EMA Tasks Working Groups With Redistributing Workloads in Run Up to Brexit (22 June 2017)

22 June 2017

Read More

Regulatory Recon: Novartis Drug Cuts Heart Attack, Stroke Risk in Phase III Trial; Kamada Withdraws EU Application for ALPHA-1 Antitrypsin Drug (22 June 2017)

22 June 2017

Read More

FDA Warns Chinese API Maker for Data Integrity Issues

21 June 2017

Read More

Regulating CRISPR: FDA and Industry Offer Perspective

21 June 2017

Read More

Gottlieb Looks to Boost Generic Drug Competition

21 June 2017

Read More

Regulatory Recon: Draft Drug Pricing Order Proposes to Ease Regulations; FDA Approves Shire's Long-Acting ADHD Drug (21 June 2017)

21 June 2017

Read More